Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Zongertinib + Trastuzumab Combinations for HER2+ Breast Cancer
Recruiting1 awardPhase 1 & 2
Iowa City, Iowa
This trial is for adults with a specific type of cancer that has spread and cannot be removed by surgery. The purpose is to find the best dose of a drug called zongertinib that can
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service